Cerebrospinal fluid levels of insulin in patients with Alzheimer's disease

Acta Neurologica Scandinavica

Volumn 106, Issue 6, 2002, Pages 347-350

  Molina, J A ^a   Jiménez Jiménez, Félix Javier ^b,c   Vargas, C ^a   Gomez P ^a   De Bustos, F ^a   Gomez Escalonilla C ^a   Zurdo, M ^b   Tallon A ^b   Martinez Salio A ^a   Porta Etessam, J ^a   Villanueva, C ^a   Arenas, J ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c NONE   (Spain)

Author keywords

Alzheimer's disease; Cerebrospinal fluid levels; Insulin

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BODY MASS; BRAIN METABOLISM; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUMAN; INSULIN BLOOD LEVEL; MALE; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PROTEIN PHOSPHORYLATION; RADIOIMMUNOASSAY; RISK ASSESSMENT;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BODY MASS INDEX; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; PSYCHOLOGICAL TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPINAL PUNCTURE;

EID: 0036917633     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2002.01326.x     Document Type: Article

References (33)

1. Messier C, Gagnon M. Glucose regulation and cognitive functions: Relation to Alzheimer's disease and diabetes. Behav Brain Res 1996;75:1-11.
2. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM. Association of diabetes mellitus and dementia: The Rotterdam Study. Diabetologia 1996;39:1392-7.
3. Leibson CL, Rocca WA, Hanson VA et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 1997;145:301-8.
4. Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 1999;16:93-112.
5. Heitner J, Dickson D. Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. Neurology 1997;49:1301-11.
6. Lannert H, Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 1998;112:1199-208.
7. Hong M, Lee VM. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 1997;272:19547-53.
8. Solano DC, Sironi M, Bonfini C, Solerte SB, Govoni S, Racchi M. Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway. FASEB J 2000;14:1015-22.
9. Gasparini L, Gouras GK, Wang R et al. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 2001;21:2561-70.
10. Boyt AA, Taddei TK, Hallmayer J et al. The effect of insulin and glucose on the plasma concentrations of Alzheimer's amyloid precursor protein. Neuroscience 2000;95:727-34.
11. Craft S, Newcomer J, Kanne S et al. Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol Aging 1996;17:123-30.
12. Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D Jr. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease. Relationship to severity of dementia and apolipoprotein E genotype. Neurology 1998;50:164-8.
13. Craft S, Asthana S, Newcomer JW et al. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatr 1999;56:1135-40.
14. Craft S, Asthana S, Schellenberg G et al. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype. Ann N Y Acad Sci 2000;903:222-8.
15. Hoyer S, Nitsch R, Oesterreich K. Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer-type: A cross-sectional comparison against advanced late-onset and incipient early-onset cases. J Neural Transm (Park Dis Dement Sect) 1991;3:1-14.
16. Adamo M, Raizada MK, Leroith D. Insulin and insulin-like growth factor receptors in the nervous system. Mol Neurobiol 1989;3:71-100.
17. Unger J, McNeill TH, Moxley RT III, White M, Moss A, Livingston JN. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 1989;31:143-57.
18. Frohlich L, Blum-Degen D, Bernstein HG et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm 1998;105:423-38.
19. Bernstein HG, Ansorge S, Riederer P, Reiser M, Frolich L, Bogerts B. Insulin-degrading enzyme in the Alzheimer's disease brain: Prominent localization in neurons and senile plaques. Neurosci Lett 1999;263:161-4.
20. Fujisawa Y, Sasaki K, Akiyama K. Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type. Biol Psychiatry 1991;30:1219-28.
21. Bucht G, Adolfsson R, Lithner F, Winblad B. Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Acta Med Scand 1983;213:387-92.
22. Meneilly GS, Hill A. Alterations in glucose metabolism in patients with Alzheimer's disease. J Am Geriatr Soc 1993;41:710-4.
23. Kuusisto J, Koivisto K, Mykkanen L et al. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: Cross sectional population based study. Br Med J 1997;315:1045-9.
24. González C, Martín T, Cacho J et al. Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers. Eur J Clin Invest 1999;29:569-70.
25. Carantoni M, Zuliani G, Munari MR, D'Elia K, Palmieri E, Fellin R. Alzheimer disease and vascular dementia: Relationships with fasting glucose and insulin levels. Dement Geriatr Cogn Disord 2000;11:176-80.
26. Razay G, Wilcock GK. Hyperinsulinemia and Alzheimer's disease. Age Ageing 1994;23:396-9.
27. Craft S, Dagogo-Jack SE, Wiethop BV et al. Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: A longitudinal study. Behav Neurosci 1993;107:926-40.
28. Kilander L, Boberg M, Lithell H. Peripheral glucose metabolism and insulin sensitivity in Alzheimer's disease. Acta Neurol Scand 1993;87:294-8.
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical Diagnosis of Alzheimer's Disease. report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:934-44.
30. Molina JA, de Bustos F, Jiménez-Jiménez FJ et al. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease. J Neural Transm 1997;104:1287-93.
31. Moreu E, Molinero LM, Fernández E. R-Sigma: Base de Datos Bioestadistica para un Ordenador Personal. Madrid: Horus Hardware, 1990.
32. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc 1996;44:1147-52.
33. Knittweiss J. Weight loss precedes Alzheimer's disease symptoms: A case study. J Am Geriatr Soc 1998;46:540-1.